Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis with Inadequate Response to Non-Biologic DMARDs Treated with Upadacitinib versus Placebo or Adalimumab: Results from a Phase 3 Study

Strand, Vibeke; Mease, Philip; Soriano, Enrique; Kishimoto, Mitsumasa; Salvarani, Carlo; Damjanov, Nemanja S; Anderson, Jaclyn K; Blondell, Erin; Zueger, Patrick; Saffore, Christopher; Gladman, Dafna

Rezultati

eNauka > Rezultati > Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis with Inadequate Response to Non-Biologic DMARDs Treated with Upadacitinib versus Placebo or Adalimumab: Results from a Phase 3 Study

Naziv :	Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis with Inadequate Response to Non-Biologic DMARDs Treated with Upadacitinib versus Placebo or Adalimumab: Results from a Phase 3 Study
Autori:	Strand, Vibeke; Mease, Philip; Soriano, Enrique; Kishimoto, Mitsumasa; Salvarani, Carlo; Damjanov, Nemanja S; Anderson, Jaclyn K; Blondell, Erin; Zueger, Patrick; Saffore, Christopher; Gladman, Dafna;
Godina:	2020
Publikacija:	ARTHRITIS & RHEUMATOLOGY
ISSN:	2326-5191 Arthritis & Rheumatology Pretraži identifikator
Tip rezultata:	Konferencijski rad
Kolacija:	vol. 72
WoS-ID:	000587568504096
URI:	https://enauka.gov.rs/handle/123456789/827798
Projekat:	AbbVie
Izvor metapodataka:	(Preuzeto iz Nasi u WoS)
M-kategorija:	Mp kategorija će biti prikazana naknadno.

Pronađi DOI

Pronalaženje DOI u servisu CrossRef-u na osnovu meta-podataka u zapisu. Prikazaće se DOI (i metapodaci) čiji se podaci najviše poklapaju. OPREZ - to ne mora biti ta publikacija.

Google Scholar^TM

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.